Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Conditions: Rectal Cancer Interventions: Drug: Camrelizumab ＋Immunotherapy Sponsors: Peking University Cancer Hospital& Institute; Beijing Nanjiao Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials